RESUMEN
INTRODUCTION: Acute pancreatitis is one of the main reasons for digestive admissions. Adequate pain treatment is crucial in its management. However, there are hardly any descriptions of the analgesic guidelines used in our setting. METHODS: On-line survey on analgesic management in acute pancreatitis, aimed at attending physicians and residents practising in Spain. RESULTS: Two hundred and nine physicians from 88 centres responded to the survey. Ninety percent were specialists in gastrointestinal medicine and 69% worked in a tertiary centre. The majority (64.4%) do not routinely use scales to measure pain. When choosing a drug, experience in its use was the most important factor. The most commonly prescribed initial treatments are: combination of paracetamol and metamizole (53.5%), paracetamol alone (19.1%) and metamizole alone (17.4%). As rescue: meperidine (54.8%), tramadol (17.8%), morphine chloride (17.8%) and metamizole (11.5%). Continuous perfusion is used in 8.2% of initial treatments. Physicians with >10 years of service use more metamizole as monotherapy (50%), while residents and attending physicians with <10 years of service prescribe it in combination with paracetamol (85%). If progression is needed, morphine chloride and meperidine are mainly used. The speciality of the respondent, the size of the work centre and the unit/service where the patients were admitted did not influence the analgesia prescribed. Satisfaction with pain management reached 7.8/10 (SD 0.98). CONCLUSION: In our setting, metamizole and paracetamol are the most commonly used analgesics as initial pain treatment in acute pancreatitis, and meperidine is the most commonly used rescue analgesic.
Asunto(s)
Analgesia , Pancreatitis , Humanos , Manejo del Dolor , Acetaminofén/uso terapéutico , Dipirona/uso terapéutico , Morfina , Enfermedad Aguda , Pancreatitis/tratamiento farmacológico , Dolor , Meperidina/uso terapéutico , Analgésicos/uso terapéuticoRESUMEN
A 54-year-old male with a medical history of diabetes mellitus type 2 and tonsil cancer treated with radiochemotherapy years previously was admitted to hospital due to one-month progressive diarrhea, epigastric pain and 14-kg weight loss. Laboratory tests revealed mild anemia (Hb 10.8 g/dl). Upper endoscopy (UE) showed multiple ulcerated lesions with raised edges and a hard consistency on biopsy, being more evident at the duodenum and with a lower frequency and smaller diameter in the stomach.
Asunto(s)
Linfoma de Burkitt , Dolor Abdominal/etiología , Biopsia , Linfoma de Burkitt/complicaciones , Linfoma de Burkitt/diagnóstico por imagen , Diarrea/etiología , Humanos , Masculino , Persona de Mediana EdadRESUMEN
INTRODUCTION: Obesity is a significant risk factor for cancer incidence and mortality. The number of patients with obesity who undergo bariatric surgery is increasing; however, the impact of such a procedure in affecting the risk of cancer is not completely understood yet. METHODS: We conducted a retrospective unicentric cohort study to characterize the occurrence of cancer in patients who underwent bariatric surgery from January 2010 to December 2018. For cases of cancer identified after bariatric surgery, we performed a cancer-free survival analysis over time. We also performed a cross-sectional analysis of demographic and clinical characteristics at the time of surgery and compared patients with or without a cancer diagnosis. RESULTS: Of the 2578 patients who underwent bariatric surgery, 117 patients (4.5%) were diagnosed with a cancer. Fifty-nine cases were diagnosed before surgery, and the remaining 58 cases occurred after the bariatric procedure. The prevalence of cancer was more accentuated in women (4.9%) than among men (2.7%). Thyroid and breast cancer were the most frequent before and after bariatric surgery, respectively. On average, patients with cancer diagnosis were older (49.0 vs 43.3 years, p<0.001) and with a lower level of education (7.4 vs 8.6 school years, p=0.002). CONCLUSION: Almost all the cases of cancer identified in this study were obesity-related cancers. Further prospective studies are needed to extend the current knowledge regarding the cancer risk profile of patients who undergo bariatric surgery.
Asunto(s)
Cirugía Bariátrica , Neoplasias de la Mama , Obesidad Mórbida , Estudios de Cohortes , Estudios Transversales , Femenino , Humanos , Masculino , Obesidad/complicaciones , Obesidad/epidemiología , Obesidad/cirugía , Obesidad Mórbida/cirugía , Estudios RetrospectivosRESUMEN
Effects of environmental factors may be transmitted to the following generation, and cause neuropsychiatric disorders including depression, anxiety, and posttraumatic stress disorder in the offspring. Enhanced synaptic plasticity induced by environmental enrichment may be also transmitted. We here test the hypothesis that the effects of brain injury in pregnant animals may produce neurological deficits in the offspring. Unilateral brain injury (UBI) by ablation of the hindlimb sensorimotor cortex in pregnant rats resulted in the development of hindlimb postural asymmetry (HL-PA), and impairment of balance and coordination in beam walking test in the offspring. The offspring of rats with the left UBI exhibited HL-PA before and after spinal cord transection with the contralesional (i.e., right) hindlimb flexion. The right UBI caused the offspring to develop HL-PA that however was cryptic and not-lateralized; it was evident only after spinalization, and was characterized by similar occurrence of the ipsi- and contralesional hindlimb flexion. The HL-PA persisted after spinalization suggesting that the asymmetry was encoded in lumbar spinal neurocircuits that control hindlimb muscles. Balance and coordination were affected by the right UBI but not the left UBI. Thus, the effects of a unilateral brain lesion in pregnant animals may be intergenerationally transmitted, and this process may depend on the side of brain injury. The results suggest the existence of left-right side-specific mechanisms that mediate transmission of the lateralized effects of brain trauma from mother to fetus.
Asunto(s)
Lesiones Traumáticas del Encéfalo , Lesiones Encefálicas , Traumatismos de la Médula Espinal , Animales , Lesiones Encefálicas/etiología , Femenino , Miembro Posterior , Plasticidad Neuronal , Embarazo , RatasAsunto(s)
Pólipos Adenomatosos/patología , ADN Glicosilasas/genética , Neoplasias Duodenales/epidemiología , Pólipos Adenomatosos/diagnóstico , Pólipos Adenomatosos/genética , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias Duodenales/diagnóstico , Neoplasias Duodenales/genética , Neoplasias Duodenales/patología , Duodenoscopía/estadística & datos numéricos , Duodeno/diagnóstico por imagen , Duodeno/patología , Femenino , Humanos , Mucosa Intestinal/diagnóstico por imagen , Mucosa Intestinal/patología , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Prospectivos , Adulto JovenRESUMEN
Este documento resume el contenido de la Guía de resección mucosa endoscópica elaborada por el grupo de trabajo de la Sociedad Española de Endoscopia Digestiva (GSEED de Resección Endoscópica) y expone las recomendaciones sobre el manejo endoscópico de las lesiones neoplásicas colorrectales superficiales (AU)
This document summarizes the contents of the Clinical Guidelines for the Endoscopic Mucosal Resection of Non-Pedunculated Colorectal Lesions that was developed by the working group of the Spanish Society of Digestive Endoscopy (GSEED of Endoscopic Resection). This document presents recommendations for the endoscopic management of superficial colorectal neoplastic lesions (AU)
Asunto(s)
Humanos , Masculino , Femenino , Resección Endoscópica de la Mucosa/métodos , Neoplasias Colorrectales/diagnóstico por imagen , Neoplasias Colorrectales/cirugía , Resección Endoscópica de la Mucosa/instrumentación , Resección Endoscópica de la Mucosa/normas , Neoplasias Colorrectales/economíaRESUMEN
Este documento resume el contenido de la Guía de resección mucosa endoscópica elaborada por el grupo de trabajo de la Sociedad Española de Endoscopia Digestiva (GSEED de Resección Endoscópica) y expone las recomendaciones sobre el manejo endoscópico de las lesiones neoplásicas colorrectales superficiales (AU)
This document summarizes the contents of the Clinical Guidelines for the Endoscopic Mucosal Resection of Non-Pedunculated Colorectal Lesions that was developed by the working group of the Spanish Society of Digestive Endoscopy (GSEED of Endoscopic Resection). This document presents recommendations for the endoscopic management of superficial colorectal neoplastic lesions (AU)
Asunto(s)
Humanos , Neoplasias Colorrectales/cirugía , Endoscopía Gastrointestinal/métodos , Resección Endoscópica de la Mucosa/métodos , Mucosa Intestinal/patología , Revisión por Pares , Selección de Paciente , Cuidados Preoperatorios/métodos , Colonoscopía/métodosRESUMEN
This document summarizes the contents of the Clinical Guidelines for the Endoscopic Mucosal Resection of Non-Pedunculated Colorectal Lesions that was developed by the working group of the Spanish Society of Digestive Endoscopy (GSEED of Endoscopic Resection). This document presents recommendations for the endoscopic management of superficial colorectal neoplastic lesions.
Asunto(s)
Neoplasias Colorrectales/cirugía , Resección Endoscópica de la Mucosa/normas , HumanosRESUMEN
This document summarizes the contents of the Clinical Guidelines for the Endoscopic Mucosal Resection of Non-Pedunculated Colorectal Lesions that was developed by the working group of the Spanish Society of Digestive Endoscopy (GSEED of Endoscopic Resection). This document presents recommendations for the endoscopic management of superficial colorectal neoplastic lesions.
Asunto(s)
Neoplasias Colorrectales/cirugía , Cirugía Colorrectal/métodos , Resección Endoscópica de la Mucosa/métodos , Endoscopía Gastrointestinal/métodos , Mucosa Intestinal/cirugía , Enfermedades del Colon/cirugía , Cirugía Colorrectal/normas , Resección Endoscópica de la Mucosa/normas , Endoscopía Gastrointestinal/normas , Humanos , Enfermedades del Recto/cirugíaRESUMEN
Spinal cord haematoma, or haematomyelia, is a rare condition caused by several unusual disease processes. Traumatic events, such as spinal cord injury and surgery or procedures involving the spinal cord, are the most important causes of spinal cord haematoma. Rarely, it is associated with anticoagulation therapy. Irrespective of cause, spinal cord haematoma is considered a neurosurgical emergency and must be treated promptly in order to prevent neurological sequelae. The authors describe the case of a 69-year-old patient taking warfarin in the therapeutic range for a mechanic mitral valve, who developed chest pain with cervical and dorsal radiation, and experienced sudden paraparesis of the limbs. A CT of the spine confirmed haematomyelia. A high index of suspicion, prompt recognition and immediate intervention are essential to prevent major morbidity and mortality from intraspinal haemorrhage. LEARNING POINTS: This article reports an unusual presentation of spontaneous spinal haematoma, imposing the careful elaboration of differential diagnoses, which is very important in internal medicine.The description of this low-incidence case allows the scientific community to assist in approaching patients with similar symptoms.The lack of studies about the etiology and treatment of spontaneous spinal haematoma underlines the need for further studies and research in the area in order to increase the scientific evidence on the approach of these patients.
RESUMEN
Abstract: Lupus miliaris disseminatus faciei is a rare inflammatory dermatosis of unknown etiology that primarily affects young adults. Clinically, it is characterized by an asymptomatic papular eruption mainly involving the central face, typically on and around the eyelids. Characteristic histopathological features include dermal epithelioid cell granulomas with central necrosis and surrounding lymphocytic infiltrate with multinucleate giant cells. Lupus miliaris disseminatus faciei has a spontaneously resolving course, yet can be cosmetically debilitating given the location and potential for scarring. Treatment is difficult and there is a lack of controlled studies. We report a new case of lupus miliaris disseminatus faciei successfully treated with minocycline and systemic steroids, and briefly discuss its nosology and therapeutic options.
Asunto(s)
Humanos , Femenino , Adulto , Dermatosis Facial/patología , Granuloma/patología , Biopsia , Prednisolona/uso terapéutico , Células Epitelioides/patología , Resultado del Tratamiento , Dermatosis Facial/tratamiento farmacológico , Glucocorticoides/uso terapéutico , Granuloma/tratamiento farmacológico , NecrosisRESUMEN
Purpose: Duodenal polyposis and cancer are important causes of morbidity and mortality in familial adenomatous polyposis (FAP) and MUTYH-associated polyposis (MAP). This study aimed to comprehensively characterize somatic genetic changes in FAP and MAP duodenal adenomas to better understand duodenal tumorigenesis in these disorders.Experimental Design: Sixty-nine adenomas were biopsied during endoscopy in 16 FAP and 10 MAP patients with duodenal polyposis. Ten FAP and 10 MAP adenomas and matched blood DNA samples were exome sequenced, 42 further adenomas underwent targeted sequencing, and 47 were studied by array comparative genomic hybridization. Findings in FAP and MAP duodenal adenomas were compared with each other and to the reported mutational landscape in FAP and MAP colorectal adenomas.Results: MAP duodenal adenomas had significantly more protein-changing somatic mutations (P = 0.018), truncating mutations (P = 0.006), and copy number variants (P = 0.005) than FAP duodenal adenomas, even though MAP patients had lower Spigelman stage duodenal polyposis. Fifteen genes were significantly recurrently mutated. Targeted sequencing of APC, KRAS, PTCHD2, and PLCL1 identified further mutations in each of these genes in additional duodenal adenomas. In contrast to MAP and FAP colorectal adenomas, neither exome nor targeted sequencing identified WTX mutations (P = 0.0017).Conclusions: The mutational landscapes in FAP and MAP duodenal adenomas overlapped with, but had significant differences to those reported in colorectal adenomas. The significantly higher burden of somatic mutations in MAP than FAP duodenal adenomas despite lower Spigelman stage disease could increase cancer risk in the context of apparently less severe benign disease. Clin Cancer Res; 23(21); 6721-32. ©2017 AACR.
Asunto(s)
Adenoma/genética , Poliposis Adenomatosa del Colon/genética , Carcinogénesis/genética , Neoplasias Duodenales/genética , Adenoma/sangre , Adenoma/patología , Poliposis Adenomatosa del Colon/sangre , Poliposis Adenomatosa del Colon/patología , Adulto , Anciano , Biopsia , ADN Glicosilasas/genética , Análisis Mutacional de ADN , ADN de Neoplasias/sangre , Neoplasias Duodenales/sangre , Neoplasias Duodenales/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proteínas de Neoplasias/genética , Secuenciación del ExomaRESUMEN
La infección por el virus de la hepatitis E es una causa clásica de hepatitis fulminante en la gestación que puede acarrear graves consecuencias materno-fetales. Las complicaciones fetales se derivan fundamentalmente de la transmisión vertical durante la gestación o el parto (hipotermia, hipoglucemia, hepatitis aguda, necrosis masiva hepática) y de un aumento de la prematuridad que conllevaría una mayor mortalidad neonatal. La peritonitis meconial se ha descrito como complicación de la infección materno-fetal por parvovirus B19, citomegalovirus, rubeola, virus de la hepatitis A y virus de la hepatitis B, sin que hayan sido comunicados en la bibliografía casos secundarios a la infección por virus de la hepatitis E. Presentamos el caso de una gestante de 19 semanas que ingresa por un cuadro de hepatitis aguda E, con diagnóstico fetal ecográfico prenatal compatible con peritonitis meconial (AU)
Hepatitis E virus infection is a classical cause of fulminant hepatitis during pregnancy, which can lead to severe maternal and fetal complications. Fetal complications are mainly derived from the vertical transmission during pregnancy or delivery (hypothermia, hypoglycaemia, acute hepatitis, massive liver necrosis) and from and increase in prematurity that would lead on to a greater neonatal mortality. Meconium peritonitis has been described as a complication of maternal and fetal infection by parvovirus B19, cytomegalovirus, rubella, hepatitis A virus and hepatitis B virus. There have been no published cases relating meconium peritonitis and hepatitis E virus infection. We present the case of a 19 week pregnant woman admitted with an acute hepatitis E, with a fetal prenatal ultrasound diagnosis of meconium peritonitis (AU)
Asunto(s)
Humanos , Femenino , Embarazo , Adulto , Peritonitis/complicaciones , Peritonitis/diagnóstico , Hepatitis E/complicaciones , Complicaciones del Embarazo/fisiopatología , Transmisión Vertical de Enfermedad Infecciosa , Hepatitis E/transmisión , Parvovirus B19 Humano/aislamiento & purificación , Parvovirus B19 Humano/patogenicidad , Leucocitosis/complicaciones , Leucocitosis/diagnóstico , Hiperbilirrubinemia/sangre , Diagnóstico Prenatal/métodos , Ascitis/diagnóstico , Hiperbilirrubinemia/complicacionesRESUMEN
BACKGROUND: Patients with type 1 diabetes mellitus (DM1) have an increased risk of celiac disease (CD). Since CD can be seronegative, more sensible tests for detection are needed. In seronegative patients, CD diagnosis may be difficult because of a lack of specificity. Flow cytometry analysis of lymphocyte populations can be useful in this situation. We aimed to study the prevalence of CD in adult DM1 using human leukocyte antigen (HLA) compatibility-based screening. A secondary goal was to study the role of flow cytometry as a complementary tool in these patients. METHODS: We selected 200 patients with DM1, of whom 190 (95%) had HLA DQ2, DQ8 or both. Of these, 136 agreed to participate and provided epidemiological data. All patients underwent blood tests and gastroscopy. RESULTS: Sixteen patients had a histology consistent with CD. After ruling out other diagnoses, 6 patients were diagnosed with CD, 2 of whom had negative antibodies. All were DQ2.5 homozygous, with a CD prevalence of 9.8% in this group. In the flow cytometry analysis of duodenal biopsy samples, when we compared all non-CD with CD patients, we found that the γ/δ intraepithelial lymphocyte (IEL) percentage was significantly higher and the CD3 negative IEL percentage significantly lower in the CD group. We found similar results when we compared only those with histological lesions. CONCLUSIONS: Screening of CD in patients with DM1 by HLA detects only 1% of seronegative patients with CD. DQ2.5 homozygous patients are at most risk of developing CD. The study of lymphocyte populations in the duodenal biopsy by flow cytometry discriminates patients with CD from those without CD with high sensitivity and specificity.
RESUMEN
Lupus miliaris disseminatus faciei is a rare inflammatory dermatosis of unknown etiology that primarily affects young adults. Clinically, it is characterized by an asymptomatic papular eruption mainly involving the central face, typically on and around the eyelids. Characteristic histopathological features include dermal epithelioid cell granulomas with central necrosis and surrounding lymphocytic infiltrate with multinucleate giant cells. Lupus miliaris disseminatus faciei has a spontaneously resolving course, yet can be cosmetically debilitating given the location and potential for scarring. Treatment is difficult and there is a lack of controlled studies. We report a new case of lupus miliaris disseminatus faciei successfully treated with minocycline and systemic steroids, and briefly discuss its nosology and therapeutic options.
Asunto(s)
Dermatosis Facial/patología , Granuloma/patología , Adulto , Biopsia , Células Epitelioides/patología , Dermatosis Facial/tratamiento farmacológico , Femenino , Glucocorticoides/uso terapéutico , Granuloma/tratamiento farmacológico , Humanos , Necrosis , Prednisolona/uso terapéutico , Resultado del TratamientoAsunto(s)
Antineoplásicos/efectos adversos , Erupciones por Medicamentos/patología , Imidazoles/efectos adversos , Indoles/efectos adversos , Oximas/efectos adversos , Paniculitis/inducido químicamente , Sulfonamidas/efectos adversos , Adulto , Anciano , Erupciones por Medicamentos/etiología , Femenino , Humanos , Melanoma/tratamiento farmacológico , Paniculitis/patología , Proteínas Proto-Oncogénicas B-raf/antagonistas & inhibidores , Neoplasias Cutáneas/tratamiento farmacológico , VemurafenibRESUMEN
No disponible